NeuroMetrix EBITDA vs. Market Capitalization
| NURO Stock | USD 4.25 0.10 2.41% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -7.1 M | Current Value -7.5 M | Quarterly Volatility 4.9 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.66 | 0.6689 |
|
|
For NeuroMetrix profitability analysis, we use financial ratios and fundamental drivers that measure the ability of NeuroMetrix to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well NeuroMetrix utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between NeuroMetrix's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of NeuroMetrix over time as well as its relative position and ranking within its peers.
NeuroMetrix |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.62) | Revenue Per Share 2.157 | Quarterly Revenue Growth (0.51) | Return On Assets (0.28) | Return On Equity (0.43) |
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NeuroMetrix Market Capitalization vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining NeuroMetrix's current stock value. Our valuation model uses many indicators to compare NeuroMetrix value to that of its competitors to determine the firm's financial worth. NeuroMetrix is rated below average in ebitda category among its peers. It is regarded fourth in market capitalization category among its peers . NeuroMetrix reported last year EBITDA of (7.1 Million). The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NeuroMetrix's earnings, one of the primary drivers of an investment's value.NeuroMetrix Market Capitalization vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
NeuroMetrix |
| = | (7.1 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
NeuroMetrix |
| = | 8.68 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
NeuroMetrix Market Capitalization vs Competition
NeuroMetrix is regarded fourth in market capitalization category among its peers. Market capitalization of Health Care industry is now estimated at about 106.95 Million. NeuroMetrix holds roughly 8.68 Million in market capitalization claiming about 8% of equities under Health Care industry.
NeuroMetrix Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in NeuroMetrix, profitability is also one of the essential criteria for including it into their portfolios because, without profit, NeuroMetrix will eventually generate negative long term returns. The profitability progress is the general direction of NeuroMetrix's change in net profit over the period of time. It can combine multiple indicators of NeuroMetrix, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 240.2 K | 252.2 K | |
| Operating Income | -7.2 M | -7.5 M | |
| Net Loss | -6.5 M | -6.9 M | |
| Income Tax Expense | (2.00) | (2.10) | |
| Income Before Tax | -6.5 M | -6.9 M | |
| Total Other Income Expense Net | 622 K | 653.1 K | |
| Net Loss | -4 M | -4.2 M | |
| Net Loss | -5.6 M | -5.9 M | |
| Non Operating Income Net Other | 3.1 K | 3 K | |
| Interest Income | 412.3 K | 648.5 K | |
| Net Interest Income | 412.3 K | 432.9 K | |
| Change To Netincome | 1.6 M | 1.6 M | |
| Net Loss | (6.27) | (6.58) | |
| Income Quality | 0.93 | 0.89 | |
| Net Income Per E B T | 0.89 | 0.65 |
NeuroMetrix Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on NeuroMetrix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of NeuroMetrix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the NeuroMetrix's important profitability drivers and their relationship over time.
Use NeuroMetrix in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NeuroMetrix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroMetrix will appreciate offsetting losses from the drop in the long position's value.NeuroMetrix Pair Trading
NeuroMetrix Pair Trading Analysis
The ability to find closely correlated positions to NeuroMetrix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NeuroMetrix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NeuroMetrix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NeuroMetrix to buy it.
The correlation of NeuroMetrix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeuroMetrix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeuroMetrix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NeuroMetrix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your NeuroMetrix position
In addition to having NeuroMetrix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Recreation Thematic Idea Now
Recreation
Companies involved in production and services of recreational goods, foods, and accessories. The Recreation theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Recreation Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Stocks Directory module to find actively traded stocks across global markets.
To fully project NeuroMetrix's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of NeuroMetrix at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include NeuroMetrix's income statement, its balance sheet, and the statement of cash flows.